Compounds and conjugates for identifying and separating post-translationally modified analytes

US2017052154A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017052154-A1
Application numberUS-201615239544-A
CountryUS
Kind codeA1
Filing dateAug 17, 2016
Priority dateAug 18, 2015
Publication dateFeb 23, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are embodiments of compounds, conjugates, and devices, such as columns comprising such compounds and/or conjugates, that can be used to identify, separate, and quantify post-translationally modified analytes. The disclosed compounds and conjugates can be used to discriminate between analytes, such as peptides, having different post-translation modifications, such as methylations, phosphorylations, acetylations, citrullinations, hydroxylations, nitrosylations, ADP-ribosylations, glycosylations, propionylations, butyrylations, crotonylations, 2-hydroxyisobutyrylations, malonylations, succinylations, formylations, ubiquitinations, neddylations, proline cis-trans isomerizations. In particular disclosed embodiments, the compounds and conjugates can be used to separate peptides having different degrees of methylation.

First claim

Opening claim text (preview).

We claim: 1 . A conjugate, comprising: a compound having a structure satisfying Formula I wherein each of A, E, G, and J independently is —N(R b ) 2 ; halogen; —SO 3 − , —CO 2 − ; aryl; heteroaryl; -linker-aryl; or -linker-heteroaryl; each of L, M, N, and Q independently is —OR b ; —O − ; —SH; —S − ; —N(R b ) 2 , -linker-aryl; or -linker-heteroaryl; each of X 1 , X 2 , X 3 , and X 4 independently is CH 2 , O, S, or NR b ; n is an integer selected from 1 to 3; each R b independently is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl; and a support component coupled to at least one of A, E, G, J, L, M, N, or Q. 2 . The conjugate of claim 1 , wherein the support component comprises a resin, a bead, a polymeric matrix, a metal oxide, a powder, a crystalline compound, an amorphous compound, or a combination thereof. 3 . The conjugate of claim 1 , wherein the support component comprises agarose, sepharose, cellulose, modified cellulose, dextran, polyacrylamide, polystyrene, latex, bonded silica gel, silica based solid, activated alumina, a polysaccharide polymer, a resinous polymer, or a combination thereof. 4 . The conjugate of claim 1 , wherein one or more of A, E, G, J, L, M, N, and Q is —N(R b ) 2 (wherein R b independently is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), aryl, heteroaryl, —NR b C(O)-aryl (wherein R b independently is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), —NR b C(O)-heteroaryl (wherein R b independently is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), —NR b SO 2 -aryl (wherein R b independently is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), —NR b SO 2 heteroaryl (wherein R b independently is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), —OC(O)-aryl, —OC(O)-heteroaryl, —OC(O)O-aryl, —OC(O)O-heteroaryl, —OSO 2 -aryl, —OSO 2 -heteroaryl, —SC(O)-aryl, or —SC(O)-heteroaryl; and the remaining of A, E, G, J, L, M, N, and Q are independently —SO 3 − , —CO 2 − , —OH, or —O − . 5 . The conjugate of claim 1 , wherein aryl is phenyl or phenyl substituted with an aliphatic moiety, a heteroaliphatic moiety, a halogen, a heteroatom-containing moiety, or a combination thereof. 6 . The conjugate of claim 5 , wherein the aliphatic moiety is alkyl, alkenyl, or alkynyl; the heteroaliphatic is moiety is alkoxy, ether, thioether, amine (—NHR b , —NR b R c , or —(CH 2 ) p NHR b , wherein R b and R c independently are hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl; and p is an integer selected from 0 to 10); the halogen is chloro, iodo, bromo, or fluoro; and the heteroatom-containing moiety is aldehyde (—(CH 2 ) p C(O)H), acyl halide (—(CH 2 ) p C(O)X, wherein X is selected from fluorine, chlorine, bromine, and iodine), carbonate (—(CH 2 ) p OC(O)OR b , wherein R b is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), carboxyl (—(CH 2 ) p C(O)OH), carboxylate (—(CH 2 ) p COO − ), ester (—(CH 2 ) p C(O)OR b ), hydroxyl (—(CH 2 ) p OH), ketone (—(CH 2 ) p C(O)R b ), peroxy (—(CH 2 ) p OOR b , wherein R b is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), hydroperoxy (—(CH 2 ) p OOH), phosphate (—(CH 2 ) p OP(O)OH 2 ), phosphoryl (—(CH 2 ) p P(O)(OH) 2 ), phosphodiester [—(CH 2 ) p (O) p (OH)OR b ), wherein R b is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl], thiol (—(CH 2 ) p SH), disulfide (—(CH 2 ) p SSR b , wherein R b is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), sulfonate (—(CH 2 ) p SO 3 − ), sulfinyl (—(CH 2 ) p S(O)R b , wherein R b is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), sulfonate ester (—(CH 2 ) p SO 2 OR b , wherein R b is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), sulfonyl (—(CH 2 ) p SO 2 OR b , wherein R b is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), carbonothioyl (—(CH 2 ) p C(S)R b or —(CH 2 ) p C(S)H, wherein R b is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), sulfino (—(CH 2 ) p S(O)OH), sulfo (—(CH 2 ) p SO 3 H), thiocyanate (—(CH 2 ) p SCN), isothiocyanate (—(CH 2 ) p NCS), oxazole, oxadiazole, imidazole, triazole, tetrazole, amide (—(CH 2 ) p C(O)NR b R c , wherein R b and R c independently are hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), azide (—(CH 2 ) p N 3 ), azo (—(CH 2 ) p NNR b , wherein R b is hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), isocyanate (—(CH 2 ) p NCO), imide (—(CH 2 ) p C(O)NR b C(O)R c , wherein R b and R c independently are hydrogen, aliphatic, heteroaliphatic, aryl, or heteroaryl), nitrile (—(CH 2 ) p CN), isonitrile (—(CH 2 ) p N + ═C − ), nitro (—(CH 2 ) p NO 2 ), nitroso (—(CH 2 ) p NO), nitromethyl (—(CH 2 ) p CH 2 NO 2 ), or —(CH 2 ) p NH 2 , wherein each p independently is an integer selected from 0 to 10. 7 . The conjugate of claim 1 , wherein: each of A, E, G, and J independently is —NH 2 , —N(C 1 -C 10 alkyl) 2 , Cl, F, Br, or I, —SO 3 − , —CO 2 − , —(CH 2 ) p Ph(CH 2 ) p (Y) m , —NHC(O)Ph(CH 2 ) p (Y) m , —NHSO 2 Ph(CH 2 ) p (Y) m , —OC(O)Ph(CH 2 ) p (Y) m , or —OSO 2 Ph(CH 2 ) p (Y) m , wherein each Y independently is positioned ortho, meta, or para on the Ph group and is aliphatic, aryl, halogen, heteroaliphatic, heteroaryl, a heteroatom-containing function group, or a combination thereof, each m is an integer selected from 0 to 4, and each p is an integer selected from 0 to 10; each L, M, N, and Q independently is —OH, —O − , —OC(O)Ph(CH 2 ) p (Y) m , —O(CH 2 ) p Y, or —OSO 2 Ph(CH 2 ) p (Y) m , wherein each Y independently is positioned ortho, meta, or para on the Ph ring and is aliphatic, aryl, halogen, heteroaliphatic, heteroaryl, a heteroatom-containing function group, or a combination thereof, and m is an integer selected from 0 to 4; each of X 1 , X 2 , X 3 , and X 4 independently can be CH 2 or S; and n is 1. 8 . The conjugate of claim 1 , wherein the compound has a formula wherein each Y is —(CH 2 ) p C(O)NH 2 , —(CH 2 ) p C(O)OH, —(CH 2 ) p NH 2 , or —(CH 2 ) p NH 3 + , each p independently is an integer selected from 0 to 10, and each m is an integer selected from 0 to 4. 9 . The conjugate of claim 1 , wherein the compound has a formula

Assignees

Inventors

Classifications

  • C08B15/00Primary

    Preparation of other cellulose derivatives or modified cellulose {, e.g. complexes} · CPC title

  • Phases chemically bonded to a substrate, e.g. to silica or to polymers · CPC title

  • Agar; Agarose, i.e. D-galactose, 3,6-anhydro-D-galactose, methylated, sulfated, e.g. from the red algae Gelidium and Gracilaria; Agaropectin; Derivatives thereof, e.g. Sepharose, i.e. crosslinked agarose · CPC title

  • by reaction, e.g. derivatising the sample · CPC title

  • on to polymers of styrene or alkyl-substituted styrenes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017052154A1 cover?
Disclosed herein are embodiments of compounds, conjugates, and devices, such as columns comprising such compounds and/or conjugates, that can be used to identify, separate, and quantify post-translationally modified analytes. The disclosed compounds and conjugates can be used to discriminate between analytes, such as peptides, having different post-translation modifications, such as methylation…
Who is the assignee on this patent?
Uvic Ind Partnerships Inc
What technology area does this patent fall under?
Primary CPC classification C08B15/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Feb 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).